Axim Biotechnologies Gross Margin Growth & History (AXIM)

Axim Biotechnologies's gross margin was 0.00% for fiscal 2019.

View full Axim Biotechnologies company overview

Axim Biotechnologies annual gross margin history

Axim Biotechnologies annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20192019-12-310.00%−95.65 pp
20182018-12-3195.65%+85.74 pp
20172017-12-319.91%+237.44 pp
20162016-12-31−227.53%−224.99 pp
20152015-12-31−2.54%

Axim Biotechnologies gross margin trends

Across the available reported history, Axim Biotechnologies's gross margin decreased from 95.65% to 0.00%, a change of −95.65 percentage points. The latest reported quarter, Q2 2024, shows 90.02%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Axim Biotechnologies filings at SEC.gov ↗